.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Pulmonary Arterial Hypertension

Review: More Investigation Needed to Understand Pathogenesis of Sch-PAH

November 27th 2021, 3:30pm

Article

Further investigation on the pathogenesis and treatment of patients with schistosome-associated pulmonary arterial hypertension (Sch-PAH) may lead to improved symptoms and higher rates of survival.

Macitentan Associated With Right Ventricular Function, Structure Improvement in PAH

November 22nd 2021, 6:00pm

Article

REPAIR study findings outline the benefits of macitentan for right ventricular functioning in pulmonary arterial hypertension.

Review: More Research Needed on Immune System to Understand PAH Pathobiology

November 20th 2021, 5:15pm

Article

While research has examined the implications of the immune system and its contributions to pulmonary arterial hypertension, further research is required to understand the pathobiology of the condition.

Study Determines PAH-SYMPACT Suitable for Use Among Patients With SAPH

November 19th 2021, 7:30pm

Article

A new study aiming to understand sarcoidosis-associated pulmonary hypertension symptoms and their impacts on patients’ lives determined that the Pulmonary Arterial Hypertension-Symptoms and Impact questionnaire could be used to suitably assess patients.

Study Identifies Potential Noninvasive Biomarkers for PAH Severity

November 12th 2021, 5:00pm

Article

Researchers in Japan identified 2 potential biomarkers for severity of pulmonary arterial hypertension (PAH) that can be measured without invasive procedures.

Researchers Push for Improved Racial Representation in PAH Registries, RCTs

November 8th 2021, 9:25pm

Article

Researchers outlined the need to combat underrepresentation of racial minorities in pulmonary arterial hypertension (PAH) registries and trials.

Patients With CTEPH Have Worse Baseline HRQOL Than Patients With IPAH

November 6th 2021, 2:50pm

Article

At baseline, patients with chronic thromboembolic pulmonary hypertension (CTEPH) had worse health-related quality of life (HRQOL) than patients with idiopathic pulmonary arterial hypertension (IPAH), but over time the scores were similar.

Analysis: Macitentan May Reduce Morbidity, Mortality of Patients With PAH on Spironolactone

November 1st 2021, 7:00pm

Article

Patients with pulmonary arterial hypertension (PAH) taking spironolactone saw a reduced risk of morbidity and mortality when receiving macitentan 10 mg.

Case Highlights Importance of Screening for Systemic Sclerosis in PAH, Raynaud

October 30th 2021, 11:40am

Article

A case study highlights the important role of nailfold videocapillaroscopy assessments in patients with Raynaud disease and pulmonary arterial hypertension (PAH).

Meta-analysis Finds Local Anesthesia Superior During Cesarean Delivery in Women With PAH

October 25th 2021, 3:30pm

Article

Local anesthesia yields superior outcomes in pregnant women with pulmonary arterial hypertension (PAH) undergoing cesarean deliveries compared with general anesthesia.